Call for Abstract
Scientific Program
30th International Conference on Cardiology and Healthcare, will be organized around the theme “Beat Goes on, with a Wealthy Heart ”
Cardiology Care 2020 is comprised of 13 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Cardiology Care 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Recent clinical bulletin addressing the cardiac implications of the novel coronavirus (COVID-19, 2019-nCoV and Wuhan Coronavirus. The key message to clinicians is that patients with underlying cardiovascular disease may have a potential increased risk if they contract coronavirus
The bulletin provides background on the epidemic, which was first reported in late December 2019, and looks at early cardiac implications from case reports. It also provides information on the potential cardiac implications from analogue viral respiratory pandemics and offers early clinical guidance given current 2019-nCoV uncertainty. It stresses the importance for cardiovascular disease patients to remain current with vaccinations, including the pneumococcal vaccine given the increased risk of secondary bacterial infection and suggests encouraging the influenza vaccination to prevent another source of fever which could be initially confused with coronavirus infection.
Cardiology is a medical specialty and a branch of internal medicine concerned with disorders of the heart. It deals with the diagnosis and treatment of such conditions as congenital heart defects, coronary artery disease, electrophysiology, heart failure and valvular heart disease. Subtopics of the cardiology include cardiac electrophysiology, echocardiography, interventional cardiology and nuclear cardiology. Hypertension is Blood pressure is the force that a person's blood exerts against the walls of their blood vessels. For cardiovascular diseases, including stroke, heart attack, heart failure, and aneurysm hypertension is a primary risk factor. Treatment drugs for hypertension include diuretics, including thiazides, chlorthalidone, and indapamide, beta-blockers and alpha-blockers, calcium-channel blockers, central agonists, peripheral adrenergic inhibitor, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers.
Heart failure is a complex clinical disorder which is a outcome of various primary and secondary causes, and shared pathways of disease progression, relating with considerable mortality, morbidity and cost. Heart failure in pediatrics is most commonly associated with coexistence of congenital heart disease, with different risks depending on the specific type of malformation. The signs and symptoms in children include, poor growth, feeding difficulties, respiratory track disorders, exercise intolerance, and fatigue, and is associated with circulatory, neurohormonal imbalance, and molecular abnormalities. Congenital heart disease is frequently associated with ventricular dysfunction, volume or pressure overload.
Heart Failure in pediatric patients with CHD has various causes, some of which overlap with the causes of cardiomyopathy, resulting in both distinct and shared mechanisms leading to ventricular dysfunction and the clinical manifestation of heart failure. We focus on basic, translational, and clinical research as it applies to heart failure in pediatric patients with CHD
The scientific goal of this track is to understand the underlying causes and pathophysiology cardio-metabolic diseases like of obesity, diabetes, and as well as pursuing effective and safe interventions and therapeutics. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Cardio-oncology describes the efforts to prevent or treat patients with cancer who are facing with heart problems due to cancer treatments. Although many cancer patients also have health conditions related to lung disease, infections or kidney disease, the rise of cardiac diseases in these patients has led to the growth of this new field. Cardio-oncology involves oncologists, cardiologists and researchers.
Cardiomyopathies are a heterogeneous group of heart muscle diseases, including dilated (DCM), hypertrophic (HCM), restrictive (RCM), arrhythmogenic right ventricular (ARVC), and nonâ€classified cardiomyopathies that frequently present as the syndrome of heart failure. The variety of causes, multiple underlying pathophysiological mechanisms and different phenotypic expressions influence their presentation and response to treatment. Although patients with cardiomyopathies have been represented in clinical trials, distinct features of their therapeutic responses, relative to other aetiologies of HF, remain unknown.
Health education, advice on cardiovascular risk reduction, physical activity and stress management are the interventions offered to patients with heart diseases in cardiac rehabilitation. Cardiac rehabilitation reduces mortality, morbidity, unplanned hospital admissions in addition to improvements in exercise capacity, quality of life and psychological well-being is increasing, and it is now recommended in international guidelines. Cardiac rehabilitation is the evidence of its benefit and effects on cardiovascular mortality, morbidity and quality of life.
Cardiac Regeneration is an effort to repair irreversibly damaged heart tissue through cutting-edge science, including stem cell and cell-free cell therapy. Reparative tools have been designed to restore damaged heart tissue and function by the natural ability of the body to regenerate. Together, patients and providers find regenerative solutions that renew, renew and recycle patients' own reparative capabilities.
- Heart Regeneration in Lower Vertebrates
- Limited Regeneration in Rodent Hearts
- The Evidence for Human Heart Regeneration
- Stem Cells and Cell Therapy
- Reprogramming Fibroblasts to Cardiomyocytes
- Tissue engineering
Cardio-metabolic disorders are assemblage of health circumstances associated with cardiovascular disease and diabetes. The morbidity and mortality severity increased clinical attention to address risk factors predisposing individuals to these cardiovascular disorders. Obesity increases the risk for heart disease and stroke. But it damages more than just the circulatory system. It even causes gallstones, osteoarthritis and respiratory problems. Obesity also can lead to heart failure. Stroke and coronary heart disease can be caused by the atherosclerosis. The medical conditions and their related risk-factors can control the complications by evidence based treatments while improving health literacy in foremost Healthcare Conferences.
Cardiovascular Engineering is a wide spectrum of research, from basic to transitive in all attributes of cardiovascular physiology and medical treatment. The distribution of research that utilizes engineering principles and methods to enhance basic knowledge and technological solutions related to cardiovascular system. Coverage ranges from subcellular to systems level topics, including other implantable medical devices such as hemodynamics, tissue biomechanics, functional imaging, surgical devices, electrical physiology, tissue engineering and regenerative methods, diagnostic tools, transmission and delivery of biologics and biosensors. Other new innovative methods are still under developing stage and can be interpreted in various Cardiology Meetings.
An innovative therapeutic approach is the use of cell therapy to counteract reverse ventricular remodelling, the substrate of heart failure and arrhythmias following myocardial infarction. Advantageous cell tissue regeneration combines a complex cellular and molecular advent setting that includes stem cell grafting and differentiation, secretion of anti-inflammatory and angiogenic mediators, and proliferation of endogenous cardiac stem cells. Recent therapeutic approaches involve adipose-derived stem cells, heart-derived stem cells, bone marrow-derived mononuclear cells and mesenchymal stem cells, and combinations of cells. Clinical trials using mesenchymal stem cells and cardiac derived stem cells have been shown to be effective in reducing infarct size and improving the contractility of regional walls. More research in undergoing in this concern and discussed in many of the Cardiology Congress.
Sports cardiology is an advancing field that encompasses the care of athletes and active individuals with known or previously undiagnosed cardiovascular conditions. It incorporates many aspects of cardiology, such as cardiac imaging, electrophysiology, structural heart disease and exercise physiology. A comprehensive sports cardiology program should include physicians with specific knowledge within these fields. The sports cardiology team should include those with expertise in the pediatric heart, especially congenital heart disease and inherited diseases, cardiovascular imagers, electrophysiologists, heart failure specialists and exercise physiologists.
Cardiology rate of increase for women much slower than other areas. Overwhelming majority of women work full-time 33% of women performed fluoro- procedures while pregnant. 29% of women did not receive any information about radiations.
Cardiovascular diseases continue to be the leading cause of death among women in the states. Sex-specific data focused on cardiovascular disease have been increasing steadily yet is not routinely collected nor translated into practice. This comprehensive review focuses on novel and unique aspects of cardiovascular health in women and sex differences as they relate to clinical practice in the prevention, diagnosis, and treatment of cardiovascular disease.
- Pregnancy-related disorders and CVD risk association
- Persistence of weight gain after pregnancy
- Radiation and chemotherapy for breast cancer
- ASA in women with diabetes mellitus
- Ischemic heart disease in women
- Acute coronary syndromes in women.
A cardiologist is a doctor who specializes in the studies of heart & its functions & also diagnosis, treatment and preventing diseases related to heart and blood vessels. You might also visit a cardiologist, so you can learn about your risk factors for heart disease and find out what measures you can take for better heart health. Cardiology – Future medicine is a field which is changing rapidly, New technologies as drug-eluting stents, assist devices for left ventricle, and novel inflammatory markers, and imaging modalities such as magnetic resonance imaging and 3D echocardiography.
- General clinical cardiologists
- Pediatric cardiologists
- Cardiovascular Anesthesiology
- Cardiovascular Pathology Research
- Preventive cardiologists.